On Jan. 16, the Center for Human-Computer Interaction + Design convened an interdisciplinary group of bold thinkers to ...

In the RELIEVE UCCD LTE phase 2b study, duvakitug showed robust, durable efficacy for an additional 44 weeks in UC and CD patients who had ...

Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s ...

TAMARAC, FL, UNITED STATES, February 17, 2026 /EINPresswire.com/ -- Tamarac, Florida , The OSHAccredited Safety ...

PLANO, TX / ACCESS Newswire / February 11, 2026 / Intrusion Inc. (NASDAQ:INTZ) ("Intrusion" or the "Company"), a leader ...

Valentine’s Day is about caring for the people who matter most. At Fort Hood, that care is demonstrated every day in a far ...

Human validation is what prevents bias, filters false alarms and ensures technology remains accountable to the people it ...

ISN, the global leader in contractor and supplier information management services, announced Tequila Sauza, a division of Suntory Global Spirits (Suntory) and leader in the beverage industry, deployed ...

Nektar Therapeutics (NKTR) stock jumps on positive mid-stage trial data for its experimental drug targeting atopic dermatitis ...

A new review including over 100 clinical trials has found that no induction method was clearly effective than low-dose vaginal misoprostol, although some methods were less effective and safety ...

Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalled Tzield pushed back after adverse event reports; bitopertin delayed two weeks amid efficacy and ...